GBIO
Price
$4.15
Change
-$0.13 (-3.04%)
Updated
Aug 7 closing price
Capitalization
27.81M
89 days until earnings call
MGNX
Price
$1.61
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Capitalization
101.58M
4 days until earnings call
Interact to see
Advertisement

GBIO vs MGNX

Header iconGBIO vs MGNX Comparison
Open Charts GBIO vs MGNXBanner chart's image
Generation Bio
Price$4.15
Change-$0.13 (-3.04%)
Volume$53.32K
Capitalization27.81M
MacroGenics
Price$1.61
Change-$0.00 (-0.00%)
Volume$256.38K
Capitalization101.58M
GBIO vs MGNX Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. MGNX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GBIO: $4.15 vs. MGNX: $1.61)
Brand notoriety: GBIO and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 36% vs. MGNX: 17%
Market capitalization -- GBIO: $27.81M vs. MGNX: $101.58M
GBIO [@Biotechnology] is valued at $27.81M. MGNX’s [@Biotechnology] market capitalization is $101.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GBIO and MGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while MGNX’s TA Score has 5 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 5 bearish.
  • MGNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а -6.53% price change this week, while MGNX (@Biotechnology) price change was +3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($102M) has a higher market cap than GBIO($27.8M). MGNX YTD gains are higher at: -50.462 vs. GBIO (-60.849). MGNX has higher annual earnings (EBITDA): -47.33M vs. GBIO (-69.2M). MGNX has more cash in the bank: 154M vs. GBIO (46.7M). MGNX has less debt than GBIO: MGNX (37.5M) vs GBIO (87.6M). MGNX has higher revenues than GBIO: MGNX (152M) vs GBIO (24.6M).
GBIOMGNXGBIO / MGNX
Capitalization27.8M102M27%
EBITDA-69.2M-47.33M146%
Gain YTD-60.849-50.462121%
P/E RatioN/AN/A-
Revenue24.6M152M16%
Total Cash46.7M154M30%
Total Debt87.6M37.5M234%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOMGNX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLLWF2.36N/A
N/A
Reliance Worldwide Corp Ltd.
SWSSF2.00N/A
N/A
Swiss Wtr Decaffinated Coffee Inc.
OTRKP0.01N/A
N/A
Ontrak, Inc.
CYDY0.26-0.01
-2.59%
CytoDyn Inc.
LSRCF97.12-12.88
-11.71%
Lasertec Corp.

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ATXS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-3.04%
ATXS - GBIO
47%
Loosely correlated
-4.44%
IDYA - GBIO
47%
Loosely correlated
-5.16%
MGNX - GBIO
46%
Loosely correlated
N/A
GLSI - GBIO
46%
Loosely correlated
-3.55%
IPSC - GBIO
45%
Loosely correlated
-2.43%
More